The Changing Landscape of Biopharma Finance
October 2nd 2020In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising capital or addressing pricing pressures to prioritizing development efforts or managing third-party risks, the landscape of Biopharma Finance is changing.
COVID-19 Action Plan for Ethics and Compliance Teams
June 26th 2020Compliance officers from the life sciences industry joined together recently to discuss how the COVID-19 pandemic has changed the ways we live and work, and how those changes have impacted the life sciences industry as a whole and will continue to do so in the future.
Tips for Promoting Drug Update in Hospitals
June 26th 2020Hospitals represent a critical access point for many therapeutics. Whether a therapeutic is indicated for use exclusively in a hospital or in both inpatient and outpatient settings, hospitals are key points of drug initiation or switching. To gain access to this channel, pharma companies must understand the needs and differences of hospital systems.
How to Select the Right Data Partner to Benefit Your Business
April 23rd 2020LexisNexis Risk Solutions takes you inside the key considerations of making the all-important choice to partner with a data provider. Go beyond the well-polished sales pitches and understand the underlying implication of finding the right fit across 5 critical areas of business.
Three Key Critical Considerations Before Embarking on Decentralized Trials
March 18th 2020- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
High-touch services that enhance patient outcomes
August 29th 2019In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.